100
Participants
Start Date
June 6, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Metagenomic Deep Sequencing (MDS)
MDS is an RNA-seq based testing of ocular fluid or tissue to identify potential infectious pathogens including bacteria, fungi, parasites, and DNA and RNA viruses.
Standard of Care (SOC)
SOC includes any available diagnostic tests, such as Gram stain, cultures, PCRs, that are considered the appropriate testing based on the clinical findings.
RECRUITING
University of California San Francisco (UCSF), San Francisco
University of Nebraska
OTHER
University of Utah
OTHER
University of California, Davis
OTHER
University of California, Los Angeles
OTHER
University of California, San Francisco
OTHER